loading

Frontiers in Colorectal and Intestinal Disease 2023

Information and registration for the flagship annual Frontiers in Colorectal and Gastrointestinal Disease Conference

Frontiers in Colorectal and Intestinal Disease 2023

St Mark’s 21st Annual International Congress, Frontiers in Colorectal and Gastrointestinal Disease  

It is my pleasure and privilege as Dean of St Mark’s Academic Institute to welcome you to London to our 21st Annual Frontiers in Colorectal and Intestinal Disease. This year the spotlight is on colorectal cancer. We look forward to welcoming a face-to-face audience to the magnificent Glaziers Hall, 9 Montague Place, London Bridge, London, SE1 9DD.

In addition, we are delighted to welcome our online audience from around the world. We will be making full use of high quality audio visual facilities to give our audience an excellent experience, whether you are with us in person, or joining us from elsewhere in the world.

The Congress will cover a broad range of topics, all of which are multidisciplinary, and encompass real issues that we deal with day-to-day in our clinics, presented by leading experts.

We will also present cutting edge research, and are honoured to have James East (UK) as our Sir Francis Avery Jones Visiting Professor, Eloy Espín Basany (Spain) as our Sir Alan Parks Visiting Professor, Rodrigo Perez (Brazil) delivering the Professor John Lennard-Jones State of the Art Lecture and Andrea Cercek (USA), who will be delivering the Basil Morson State of the Art Lecture.

We will combine medical, endoscopic, radiological, oncological, surgical, nursing and nutritional expertise throughout the programme, and also ensure that our patients’ voice is loudly heard

The Congress is organised into a number of plenary sessions:

On Wednesday, we have sessions focusing on emergencies in colorectal cancer management, screening and diagnosis of colorectal neoplasia, endoscopic and surgical approaches to managing colorectal neoplasia, and the science of prehabilitation.

On Thursday, we will start with hearing the patients’ voice expressing their perspective on what is successful cancer treatment. This will be followed by how to best manage right-sided colorectal cancer, sessions on frontiers in colorectal cancer imaging, macro-management of colorectal cancer (is centralisation the solution?), cancer genetics and the role of immunotherapy.

Also on Thursday, we have a parallel meeting for inflammatory bowel disease, with sessions on ulcerative colitis, Crohn’s disease, and an afternoon dedicated to developing and delivering consistent models of care for monitoring patients, diet and IBD, and mental health issues in IBD patients.

On Friday, we will look at rectal cancer management, rare and complex cancers and the aftermath of colorectal cancer and its treatment.

We conclude our symposium with an interactive informal session with all the leading lights coming together for what should be an enlightening and entertaining discussion in ‘Have I got views for you’.

We would like to take this opportunity to express our gratitude to all sponsors for their support and contribution to this Congress.

We hope that you will find the next few days interesting, stimulating, educational and, at times, controversial.

We wish you an enjoyable time in London for the 21st Meeting of the Frontiers Congress.

This event is endorsed by ECCO and by BSG.  Attendees  will receive 15 CPD points.

Frontiers Timetable

08/11/2023

08:00–17:30

Registration & Welcome

Emergencies in colorectal cancer management: In this session, we will consider the management of emergency presentations of colorectal cancer patients.

Colorectal cancer: screening and diagnosis: In this session, we will explore colorectal cancer screening and surveillance pathways and how to optimise colorectal cancer detection and recognition.

Sir Francis Avery Jones Lecture: Managing dysplasia in inflammatory bowel disease – James East

Colorectal cancer: endoscopic and surgical approaches: In this session, we will look at selection of the optimal therapeutic approach for advanced neoplasia or colorectal cancer and how to work with colleagues to deliver effective and safe therapeutics.

John Nicholls Prize

09/11/2023

09:00–17:30

What is successful cancer treatment? The patient’s voice: Claire Taylor, Natalie Woodward

Optimising management of right-sided colon cancer: In this session, we will discuss the challenges and solutions in the management of right- sided colon cancer.

Frontiers in colorectal cancer imaging: In this session, we will explore state of the art technologies, artificial intelligence and augmented reality for advanced imaging changing clinical practice in colorectal cancer treatment.

Sir Alan Parks Lecture: The macro-management of cancer – is centralisation the only solution? Eloy Espín Basany

All cancer is genetic? The Lynch pin of disease: In this session, we will look at increasing the understanding of hereditary cancers and underlying cancer biology, and implications for treatment.

Basil Morson State of the Art Lecture: Immunotherapy – the Bellerophon – Andrea Cercek

Treating the untreatable: In this session, we explore the management opportunities for colorectal cancer patients in challenging situations.

09/11/2023 Parallel IBD Meeting

09:00–17:15

Ulcerative colitis: In this session, we will look at hitting the inflammatory target with our best drugs early and hard in ulcerative colitis patients, what to do when hitting inflammation hard is not hard enough and consider checklists and algorithms for patients undergoing surgery to achieve optimal outcomes.

Crohn’s disease: In this session, we will look at the trickier aspects of Crohn’s disease management from top to bottom, looking at diagnostic dilemmas, optimising patients for surgery, and managing refractory and perianal Crohn’s disease.

“The glue that holds the IBD patient together”: In this session, we will look at developing and delivering consistent models of care for monitoring patients, answering patients’ questions about diet and IBD, when and how to offer psychological support and can we do better at treating mental health issues in IBD patients.

State of the art lecture: IBD in 2050… what does the future look like? James Lee

MDT case discussion: Cases discussed amongst the multidisciplinary team

10/11/2023

09:00-17:30

Frontiers in rectal cancer management: In this session, we will explore the current controversies at the cutting edge of rectal cancer management.

Lennard-Jones State of the Art Lecture: Watch and wait in rectal cancer. Wait… did we watch for too long? Rodrigo Perez

Rare cancers: In this session, we look at surveillance, diagnosis and management of rare intestinal and colorectal cancers.

Complex cancer – a patient journey: In this session, we will present case histories to explore what is meant by the term complex cancer and how to optimise management for an individual patient.

The aftermath – impact of colorectal cancer and its treatment: In this session, we look at the impact of colorectal cancer and its treatment on functional and clinical long term outcomes.

Frontiers External Speakers

Andrea Cercek
Andrea Cercek

Guest Speaker

Memorial State Kettering Cancer Center, New York

James East
James East

Guest Speaker

John Radcliffe Hospital, Oxford, UK

Eloy Espín Basany
Eloy Espín Basany

Guest Speaker

Barcelona, Spain

Rodrigo Perez
Rodrigo Perez

Guest Speaker

Hospital Alemão Oswaldo Cruz, São Paulo, Brazil

Programme (pdf)

Register Now